Neoadjuvant immunotherapy in early-stage triple negative breast cancer

Panayiotis Laouris; Mariana Espirito Santo Rodrigues; Susanne Crocamo Ventilary Costa; Bruno Henrique Rala de Paula

doi:10.21037/atm-23-1550

Neoadjuvant immunotherapy in early-stage triple negative breast cancer

Ann Transl Med. 2023 Aug 30;11(10):338. doi: 10.21037/atm-23-1550. Epub 2023 Jun 27.

Authors

Panayiotis Laouris¹, Mariana Espirito Santo Rodrigues¹, Susanne Crocamo Ventilary Costa¹, Bruno Henrique Rala de Paula¹

Affiliation

¹ Early Phase Trials Unit, Division of Oncology, University of Cambridge, Cambridge, UK.

No abstract available

Keywords: HER2-negative breast cancer; Neoadjuvant immunotherapy; pseudomonas aeruginosa mannose-sensitive hemagglutinin (PA-MSHA); triple-negative breast cancer (TNBC).

Publication types

Editorial
Comment